Troy Wanandy, Simon A Handley, Thanh-Thao Adriana Le, Wun Yee Lau, Malcolm E Turner, Michael D Wiese
{"title":"Stability of antibiotics for use in the testing of immediate drug allergy reactions.","authors":"Troy Wanandy, Simon A Handley, Thanh-Thao Adriana Le, Wun Yee Lau, Malcolm E Turner, Michael D Wiese","doi":"10.1016/j.jaip.2024.10.040","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Limited information is available regarding the physicochemical stability of penicillins-based preparations for skin testing purposes and no information is currently available for other classes of antibiotics.</p><p><strong>Objective: </strong>To perform chemical and physical stability studies on 16 parenteral antibiotics for skin testing purposes, with an overall aim to provide practical recommendations to clinicians on suitable components, storage, and optimal shelf-life of such preparations.</p><p><strong>Methods: </strong>Chemical stability was assessed via validated stability-indicating high performance liquid chromatography with ultraviolet detection assays, while absence of precipitations or haziness, significant pH shift and colour change were used to determine physical stability.</p><p><strong>Results: </strong>Other than amoxicillin/clavulanic acid, all of the parenteral antibiotics were found to have adequate physicochemical stability between 2 to 7 days. Amoxicillin in Water for Injection BP retained >90% stability, while amoxicillin/clavulanic acid dropped to <80%. Ampicillin remained >90% stable for 2 days, and benzylpenicillin, flucloxacillin, and piperacillin/tazobactam were stable for ≥2 days at ∼95%. Cephalosporins were stable for 2 days, except ceftazidime, which increased to >110%. Aztreonam, ciprofloxacin, and vancomycin retained >95% stability for 7 days, while meropenem was stable for 2 days. Sulfamethoxazole/trimethoprim lost 15% but stabilized at ∼85% for 7 days. No precipitation occurred, but amoxicillin/clavulanic acid changed colour by day 7. pH decreases of ≤1.0 unit were observed in penicillins, while cefepime dropped below acceptable pH limits by day 7. Absorbance shifts >100 units were seen in several antibiotics by day 7.</p><p><strong>Conclusions: </strong>This study has generated practical stability information for clinicians, allowing 15 parenteral antibiotics from 7 different classes to be aseptically prepared in advance for use in the testing of drug allergy reactions.</p>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaip.2024.10.040","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Limited information is available regarding the physicochemical stability of penicillins-based preparations for skin testing purposes and no information is currently available for other classes of antibiotics.
Objective: To perform chemical and physical stability studies on 16 parenteral antibiotics for skin testing purposes, with an overall aim to provide practical recommendations to clinicians on suitable components, storage, and optimal shelf-life of such preparations.
Methods: Chemical stability was assessed via validated stability-indicating high performance liquid chromatography with ultraviolet detection assays, while absence of precipitations or haziness, significant pH shift and colour change were used to determine physical stability.
Results: Other than amoxicillin/clavulanic acid, all of the parenteral antibiotics were found to have adequate physicochemical stability between 2 to 7 days. Amoxicillin in Water for Injection BP retained >90% stability, while amoxicillin/clavulanic acid dropped to <80%. Ampicillin remained >90% stable for 2 days, and benzylpenicillin, flucloxacillin, and piperacillin/tazobactam were stable for ≥2 days at ∼95%. Cephalosporins were stable for 2 days, except ceftazidime, which increased to >110%. Aztreonam, ciprofloxacin, and vancomycin retained >95% stability for 7 days, while meropenem was stable for 2 days. Sulfamethoxazole/trimethoprim lost 15% but stabilized at ∼85% for 7 days. No precipitation occurred, but amoxicillin/clavulanic acid changed colour by day 7. pH decreases of ≤1.0 unit were observed in penicillins, while cefepime dropped below acceptable pH limits by day 7. Absorbance shifts >100 units were seen in several antibiotics by day 7.
Conclusions: This study has generated practical stability information for clinicians, allowing 15 parenteral antibiotics from 7 different classes to be aseptically prepared in advance for use in the testing of drug allergy reactions.
期刊介绍:
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases.
This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders.
The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.